Expression of Stefin A is of Prognostic Significance in Squamous Cell Carcinoma of the Head and Neck

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2013 Apr 3

PMID 23545885

Citations 7

Authors

Aleksandar Anicin

Nina Gale

Lojze Smid

Janko Kos

Primoz Strojan

Affiliations

Soon will be listed here.

Abstract

Lysosomal proteases cathepsins B and L (CB, CL) and their endogenous inhibitors stefins A and B (SA, SB) are associated with tumor cell invasion and metastasis. The purpose of this study was to determine the immunohistochemical (IHC) localization of these parameters in tissue sections of 65 patients with operable head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic significance of the observed IHC reactions. In SCC cells, a dot-like staining pattern for CB and CL was especially polarized in the perinuclear area and for stefins the characteristic IHC pattern was a diffuse cytoplasmic reaction. Higher SA immunoreactivity scores were found prognostically advantageous in univariate survival analysis [locoregional control (LRC), P = 0.003; disease-free survival (DFS), P = 0.023; disease-specific survival (DSS), P = 0.030] and appeared significant for predicting LRC (P = 0.019) in a multivariate setting. Among node-positive extracapsular extension-negative patients, SA positivity correlated with a favorable outcome (LRC, P = 0.094; DFS, P = 0.013; DSS, P = 0.012). In conclusion, SA immunoreactivity in tumor cells was related to a favorable prognosis. In the neck node-positive extracapsular extension-negative subgroup, SA immunoreactivity scores can be used to identify patients at increased risk for disease relapse.

Citing Articles

Biomarker cystatin B expression correlates with pathogenesis in cervical cancer.

Ye D, Duan X, Guan B, Yuan J, Zhu Y, Shi J J Int Med Res. 2024; 52(3):3000605241233959.

PMID: 38436260 PMC: 10913530. DOI: 10.1177/03000605241233959.

In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer.

Rudzinska-Radecka M, Frolova A, Balakireva A, Gorokhovets N, Pokrovsky V, Sokolova D Cells. 2022; 11(9).

PMID: 35563761 PMC: 9101197. DOI: 10.3390/cells11091455.

Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.

Humphries F, Chang-McDonald B, Patel J, Bockett N, Paterson E, Davis P Front Oncol. 2021; 11:690460.

PMID: 34621666 PMC: 8491843. DOI: 10.3389/fonc.2021.690460.

Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.

Li C, Cai J, Tsai J, Wang C Front Oncol. 2020; 10:681.

PMID: 32528874 PMC: 7258718. DOI: 10.3389/fonc.2020.00681.

Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma.

Komura T, Takabatake H, Harada K, Yamato M, Miyazawa M, Yoshida K Cancer Sci. 2017; 108(11):2122-2129.

PMID: 28898495 PMC: 5666027. DOI: 10.1111/cas.13396.

References

Lah T, Kalman E, Najjar D, Gorodetsky E, Brennan P, Somers R . Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis. Hum Pathol. 2000; 31(2):149-60. DOI: 10.1016/s0046-8177(00)80214-2. View

Bernier J, Cooper J, Pajak T, Van Glabbeke M, Bourhis J, Forastiere A . Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27(10):843-50. DOI: 10.1002/hed.20279. View

Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J . Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2000; 6(3):1052-62. View

Xu X, Yuan G, Liu W, Zhang Y, Chen W . Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance. Exp Oncol. 2009; 31(2):102-5. View

Yang X, Wei K, Zhang L, Pan H, Li J, Chen W . Increased expression of Cathepsin B in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010; 39(2):174-81. DOI: 10.1016/j.ijom.2009.11.018. View

Li C, Chen L, Wang J, Zhang L, Tang P, Zhai S . Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer. Oncol Rep. 2011; 26(4):869-75. DOI: 10.3892/or.2011.1344. View

Parker B, Ciocca D, Bidwell B, Gago F, Fanelli M, George J . Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol. 2007; 214(3):337-46. DOI: 10.1002/path.2265. View

Kawasaki G, Kato Y, Mizuno A . Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93(4):446-54. DOI: 10.1067/moe.2002.122834. View

Mehanna H, West C, Nutting C, Paleri V . Head and neck cancer--Part 2: Treatment and prognostic factors. BMJ. 2010; 341:c4690. DOI: 10.1136/bmj.c4690. View

10.

Strojnik T, Kos J, Zidanik B, Golouh R, Lah T . Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res. 1999; 5(3):559-67. View

11.

Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller D, Zacharias W . Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol. 2000; 31(8):931-7. DOI: 10.1053/hupa.2000.9035. View

12.

Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I . Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe Seyler. 1995; 376(7):401-5. DOI: 10.1515/bchm3.1995.376.7.401. View

13.

Macabeo-Ong M, Shiboski C, Silverman S, Ginzinger D, Dekker N, Wong D . Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol. 2003; 39(7):638-47. DOI: 10.1016/s1368-8375(03)00034-4. View

14.

Sinha A, Quast B, Wilson M, Fernandes E, Reddy P, Ewing S . Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer. 2002; 94(12):3141-9. DOI: 10.1002/cncr.10604. View

15.

Nikitakis N, Rivera H, Lopes M, Siavash H, Reynolds M, Ord R . Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am J Clin Pathol. 2003; 119(4):574-86. DOI: 10.1309/JD3D-HGCD-GAUN-1R0J. View

16.

Li W, Ding F, Zhang L, Liu Z, Wu Y, Luo A . Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis. Clin Cancer Res. 2005; 11(24 Pt 1):8753-62. DOI: 10.1158/1078-0432.CCR-05-0597. View

17.

Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R . High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006; 24(36):5630-6. DOI: 10.1200/JCO.2005.04.6136. View

18.

Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977; 35(1):1-39. PMC: 2025310. DOI: 10.1038/bjc.1977.1. View

19.

Nagaraj N, Zacharias W . Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells. Toxicol Lett. 2007; 170(2):134-45. PMC: 1952681. DOI: 10.1016/j.toxlet.2007.02.014. View

20.

Wickramasinghe N, Banerjee K, Nagaraj N, Vigneswaran N, Zacharias W . Hypoxia alters cathepsin B / inhibitor profiles in oral carcinoma cell lines. Anticancer Res. 2005; 25(4):2841-9. View